SCHEMBL7469487

SCHEMBL7469487

CCCCCC(=O)Nc1c[c]ccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
POLB P06746 2/20 0.56
SOAT2 O75908 1/20 0.56
SOAT1 P35610 1/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HDAC8 Q9BY41 4/20 0.50
HDAC3 O15379 3/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC2 Q92769 2/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ICMT O60725 1/20 0.49
ALB P02768 1/20 0.49
MEN1 O00255 1/20 0.48
GAA P10253 1/20 0.48
KMT2A Q03164 1/20 0.48
NAMPT P43490 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152735 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL8356323 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL9095488 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL6537046 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL9739986 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL11715260 0.98 LMNA (0.58) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL7320242 0.95 ALDH1A1 (0.52) LMNAPOLBSOAT2SOAT1NPC1
SCHEMBL1418810 0.89 ALDH1A1 (0.57) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL1418948 0.88 EPHX2 (0.47) LMNAPOLBSOAT2SOAT1HDAC8
SCHEMBL1419150 0.86 FNTA (0.46) LMNAPOLBSOAT2SOAT1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1343206-A Cyclocompound FUJISAWA PHARMACEUTICAL CO (JP) 2002-04-03 CN claimed
EP-0650476-B1 PERIPHERAL VASODILATING AGENT CONTAINING N-ACYLATED 4-AMINO PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS OTSUKA PHARMA CO LTD (JP) 2002-06-26 EP disclosed
CN-1343206-A Cyclocompound FUJISAWA PHARMACEUTICAL CO (JP) 2002-04-03 CN disclosed
US-6136826-A AMINOPIPERIDINE COMPOUNDS SUBSTITUTED WITH ALKANOYL OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-10-24 US disclosed
CN-1052224-C Peripheral Vasodilating agent containing N-acylated 4-amino piperidine derivatives as active ingredients OTSUKA PHARMA CO LTD (JP) 2000-05-10 CN disclosed
US-5760058-A Peripheral vasodilating agent containing piperidine derivative as active ingredient OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-06-02 US disclosed
US-5656642-A Peripheral vasodilating agent containing piperidine derivative as active ingredient OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-08-12 US disclosed
WO-1994022826-A1 PERIPHERAL VASODILATING AGENT CONTAINING N-ACYLATED 4-AMINO PIPERIDINE DERIVATIVES AS ACTIVE INGREDIENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-13 WO disclosed
US-3993645-A Stilbene optical brighteners and compositions brightened therewith STERLING DRUG INC. (US) 1976-11-23 US disclosed
US-3974144-A BENZOFURAN, BENZOTHIOPHENE, NAPHTHOFURAN, OPTICAL BRIGHTENER STERLING DRUG INC. (US) 1976-08-10 US disclosed
US-3932301-A NYLON, POLYESTERS STERLING DRUG INC. (US) 1976-01-13 US disclosed